Inventor

OLWILL SHANE

DE20 patents

⚠️ This page may combine multiple inventors who share the name “OLWILL SHANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OLWILL SHANE

PIERIS PHARMACEUTICALS GMBH

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

Proteins specific for CD137

Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

Proteins specific for CD137

Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)

Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides

Lipocalin muteins with binding affinity for LAG-3

Lipocalin muteins with binding affinity for LAG-3

Multi-specific polypeptide useful for localized tumor immunomodulation

Anti-cancer fusion polypeptide

Fusion proteins specific for CD137 and GPC3

PIERIS AG

Methods and compositions for treating disorders

SCOTT CHRISTOPHER

Antibody and uses thereof

FUSION ANTIBODIES LTD

Antibody and uses thereof

CASWELL JILL

Anti-AREG/HB-EGF antibodies and treatment

OLWILL SHANE

Therapy targeting cathepsin S

PIERIS AUSTRALIA PTY LTD

Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)